These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 748092)
41. Plasma glucose, insulin, pancreatic, and enteroglucagon levels in normal and depancreatized dogs. Matsuyama T; Foà PP Proc Soc Exp Biol Med; 1974 Oct; 147(1):97-102. PubMed ID: 4438349 [No Abstract] [Full Text] [Related]
42. Interactions between glucagon and other counterregulatory hormones during normoglycemic and hypoglycemic exercise in dogs. Wasserman DH; Lickley HL; Vranic M J Clin Invest; 1984 Oct; 74(4):1404-13. PubMed ID: 6148356 [TBL] [Abstract][Full Text] [Related]
43. Failure of somatostatin to modify effect of glucagon on carbohydrate metabolism in the dog. Cherrington AD; Lacy WW; Williams PE; Steiner KE Am J Physiol; 1983 Jun; 244(6):E596-602. PubMed ID: 6134474 [TBL] [Abstract][Full Text] [Related]
44. Pharmacokinetics and bioavailability of injected glucagon: differences between intramuscular, subcutaneous, and intravenous administration. Mühlhauser I; Koch J; Berger M Diabetes Care; 1985; 8(1):39-42. PubMed ID: 3971846 [TBL] [Abstract][Full Text] [Related]
45. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia. Rizza RA; Cryer PE; Gerich JE J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413 [TBL] [Abstract][Full Text] [Related]
46. Response of extrapancreatic glucagon to glycemic changes under chronic insulin deficiency in dogs. Kobayashi T; Nihei J; Ohneda A Tohoku J Exp Med; 1983 Dec; 141(4):481-8. PubMed ID: 6367144 [TBL] [Abstract][Full Text] [Related]
47. Effect of centrally administered glucagon on liver glycogen & enzymes in anaesthetised dogs. Agarwala GC; Mishra R; Jaiswal G; Bapat V Indian J Med Res; 1989 Oct; 90():372-8. PubMed ID: 2628307 [TBL] [Abstract][Full Text] [Related]
48. Effect of centrally administered glucagon on blood lipids in anesthetised dogs. Agarwala GC; Mishra R; Jaiswal G; Bapat V Indian J Physiol Pharmacol; 1986; 30(4):280-8. PubMed ID: 3570427 [TBL] [Abstract][Full Text] [Related]
49. Exercise-induced changes in insulin and glucagon are not required for enhanced hepatic glucose uptake after exercise but influence the fate of glucose within the liver. Pencek RR; James FD; Lacy DB; Jabbour K; Williams PE; Fueger PT; Wasserman DH Diabetes; 2004 Dec; 53(12):3041-7. PubMed ID: 15561932 [TBL] [Abstract][Full Text] [Related]
50. Effects of subcutaneous, low-dose glucagon on insulin-induced mild hypoglycaemia in patients with insulin pump treated type 1 diabetes. Ranjan A; Schmidt S; Madsbad S; Holst JJ; Nørgaard K Diabetes Obes Metab; 2016 Apr; 18(4):410-8. PubMed ID: 26743775 [TBL] [Abstract][Full Text] [Related]
51. Extrapancreatic effect of somatostatin infusion to increase glucose clearance. Bergman RN; Ader M; Finegood DT; Pacini G Am J Physiol; 1984 Sep; 247(3 Pt 1):E370-9. PubMed ID: 6148014 [TBL] [Abstract][Full Text] [Related]
52. Effect of insulin on the response of gut glucagon-like immunoreactivity (GLI) to oral glucose and food ingestion in the goose. Karmann H; Mialhe P Horm Metab Res; 1987 Feb; 19(2):47-52. PubMed ID: 3549502 [TBL] [Abstract][Full Text] [Related]
53. Regulation of glucose turnover during exercise in pancreatectomized, totally insulin-deficient dogs. Effects of beta-adrenergic blockade. Bjorkman O; Miles P; Wasserman D; Lickley L; Vranic M J Clin Invest; 1988 Jun; 81(6):1759-67. PubMed ID: 3290252 [TBL] [Abstract][Full Text] [Related]
55. Effects of subbasal insulin infusion on resting and exercise-induced glucose turnover in depancreatized dogs. Shi ZQ; Giacca A; Yamatani K; Fisher SJ; Lickley HL; Vranic M Am J Physiol; 1993 Mar; 264(3 Pt 1):E334-41. PubMed ID: 8460681 [TBL] [Abstract][Full Text] [Related]
56. The metabolic and hormonal responses to a mixed meal in unrestrained pancreatectomised dogs chronically treated by portal or peripheral insulin infusion. Goriya Y; Bahoric A; Marliss EB; Zinman B; Albisser AM Diabetologia; 1981 Jul; 21(1):58-64. PubMed ID: 7024031 [TBL] [Abstract][Full Text] [Related]
57. The evaluation of glucagon infusion algorithms for a counterregulatory system in artificial endocrine pancreas. Yagi T; Yamasaki Y; Bando K; Kawamori R; Kamada T; Shichiri M Med Prog Technol; 1988; 13(4):195-201. PubMed ID: 2972904 [TBL] [Abstract][Full Text] [Related]
58. Low-dose IGF-I has no selective advantage over insulin in regulating glucose metabolism in hyperglycemic depancreatized dogs. Fisher SJ; Shi ZQ; Lickley HL; Efendic S; Vranic M; Giacca A J Endocrinol; 2001 Jan; 168(1):49-58. PubMed ID: 11139769 [TBL] [Abstract][Full Text] [Related]
59. Essential roles of insulin and glucagon in regulating glucose fluxes during exercise in dogs. Vranic M; Kawamori R Diabetes; 1979 Jan; 28 Suppl 1():45-52. PubMed ID: 761713 [No Abstract] [Full Text] [Related]
60. Superactive somatostatin analog decreases plasma glucose and glucagon levels in diabetic rats. Karashima T; Schally AV Peptides; 1988; 9(3):561-5. PubMed ID: 2901737 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]